Andreas Viardot

机构：Universität Ulm, University Hospital Ulm · ORCID：0000-0001-9593-6327

发表论文 284 篇 · 总被引 12871 次 · h-index 46

代表论文

• Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study (2024 · Nature Medicine · 被引 146)
• Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial (2024 · The Lancet · 被引 140)
• Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update (2024 · Blood · 被引 97)
• Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma (2025 · Blood Advances · 被引 39)
• Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study (2024 · Blood Advances · 被引 33)
• CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma: towards a rational approach (2023 · The Lancet Haematology · 被引 17)